Data could support future efforts to make real-time CGM a standard tool for glycemic assessment in the hospital setting Real-world evidence will be gathered from healthcare providers and hospital institutions using real-time CGM with hospitalized patients SAN DIEGO --(BUSINESS WIRE)--Sep.

SAN DIEGO --(BUSINESS WIRE)--Sep. 4, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences: Steve Pacelli , Executive Vice President Strategy and Corporate Development, and Jereme Sylvain , Senior

SAN DIEGO --(BUSINESS WIRE)--Aug. 12, 2020-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Karen Dahut to its Board of Directors, effective immediately. Ms. Dahut has more than 25 years of leadership experience in

SAN DIEGO --(BUSINESS WIRE)--Aug. 10, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Quentin Blackford , Chief Operating Officer and Chief Financial Officer, and Steve Pacelli , Executive Vice

SAN DIEGO --(BUSINESS WIRE)--Jul. 28, 2020-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2020 . Second Quarter 2020 Financial Highlights: Revenue grew 34% versus the same quarter of the prior year to $451.8 million U.S.

TORONTO , July 16, 2020 /CNW/ - Last week, Health Canada temporarily authorized the adjunctive use of the Dexcom G6 Continuous Glucose Monitoring (CGM) system by pregnant women with Type 1, Type 2, or gestational diabetes. This temporary expanded indication was granted because of the active role

SAN DIEGO --(BUSINESS WIRE)--Jun. 30, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2020 financial results after market close on Tuesday, July 28, 2020 . Management will hold a conference call to review the company's second quarter 2020 performance

SAN DIEGO --(BUSINESS WIRE)--Jun. 4, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steve Pacelli , Executive Vice President, Strategy and Corporate Development, will present on behalf of the company

SAN DIEGO --(BUSINESS WIRE)--May 12, 2020-- DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today the pricing of its offering of $1.05 billion aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private placement to qualified institutional buyers pursuant to

SAN DIEGO --(BUSINESS WIRE)--May 11, 2020-- DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $850.0 million aggregate principal amount of Convertible Senior Notes due 2025 (the “notes”) in a private placement to